156 related articles for article (PubMed ID: 36213089)
21. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease.
Liu D; Peng SH; Zhang J; Bai SH; Liu HX; Qu JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1265-73. PubMed ID: 26170655
[TBL] [Abstract][Full Text] [Related]
22. Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
Dransfield MT; Criner GJ; Halpin DMG; Han MK; Hartley B; Kalhan R; Lange P; Lipson DA; Martinez FJ; Midwinter D; Singh D; Wise R; Kunisaki KM
J Am Heart Assoc; 2022 Sep; 11(18):e024350. PubMed ID: 36102236
[TBL] [Abstract][Full Text] [Related]
23. Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.
Løkke A; Hilberg O; Lange P; Ibsen R; Stratelis G; de Fine Licht S; Lykkegaard J
Int J Chron Obstruct Pulmon Dis; 2022; 17():569-578. PubMed ID: 35321533
[TBL] [Abstract][Full Text] [Related]
24. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
[TBL] [Abstract][Full Text] [Related]
25. Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort.
Meeraus WH; Mullerova H; El Baou C; Fahey M; Hessel EM; Fahy WA
Int J Chron Obstruct Pulmon Dis; 2021; 16():225-244. PubMed ID: 33574663
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR; Vestbo J; Anzueto A; Locantore N; Müllerova H; Tal-Singer R; Miller B; Lomas DA; Agusti A; Macnee W; Calverley P; Rennard S; Wouters EF; Wedzicha JA;
N Engl J Med; 2010 Sep; 363(12):1128-38. PubMed ID: 20843247
[TBL] [Abstract][Full Text] [Related]
27. A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study.
Koskela HO; Salonen PH; Romppanen J; Niskanen L
BMJ Open; 2015 Jan; 5(1):e006794. PubMed ID: 25633287
[TBL] [Abstract][Full Text] [Related]
28. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
[TBL] [Abstract][Full Text] [Related]
29. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
30. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
[TBL] [Abstract][Full Text] [Related]
31. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
[TBL] [Abstract][Full Text] [Related]
32. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
33. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease.
Kocks JW; van den Berg JW; Kerstjens HA; Uil SM; Vonk JM; de Jong YP; Tsiligianni IG; van der Molen T
Int J Chron Obstruct Pulmon Dis; 2013; 8():273-86. PubMed ID: 23766644
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a.
Wang Y; Lyu X; Wu X; Yu L; Hu K
J Clin Lab Anal; 2020 Aug; 34(8):e23346. PubMed ID: 32342557
[TBL] [Abstract][Full Text] [Related]
35. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
Daniels K; Lanes S; Tave A; Pollack MF; Mannino DM; Criner G; Neikirk A; Rhodes K; Feigler N; Nordon C
Int J Chron Obstruct Pulmon Dis; 2024; 19():225-241. PubMed ID: 38259591
[TBL] [Abstract][Full Text] [Related]
36. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
37. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
38. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
Aydemir Y; Aydemir Ö; Kalem F
Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
[TBL] [Abstract][Full Text] [Related]
40. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
